Latest News in the pharma Industry

Market News

Positive update on the development of new XF‐platform drug formulations

Positive update on the development of new XF‐platform drug formulations

24 Mar 2020

Collaboration with MedPharm delivers data profiling new XF‐platform drug formulations as potential treatments for dermal and ocular infections.

Read more 
ProBioGen selected for development and large-scale manufacturing services

ProBioGen selected for development and large-scale manufacturing services

24 Mar 2020

The Contract Development and Manufacturing Organization (CDMO) and technology provider will use its CHO.RiGHT expression platform for high-titer cell line development.

Read more 
Codexis and Takeda collaborate to advance novel gene therapies

Codexis and Takeda collaborate to advance novel gene therapies

23 Mar 2020

Partnership to leverage Codexis’ protein engineering platform for the discovery and development of novel transgenes for lysosomal storage disorders and blood factor deficiencies.

Read more 
Lonza's new medium boosts and optimizes AAV production in insect cells

Lonza's new medium boosts and optimizes AAV production in insect cells

23 Mar 2020

The TheraPEAK SfAAV Medium is specifically designed to support the development of safe, scalable, gene therapies.

Read more 
Helsinn receives European approval of its IV formulation of Akynzeo

Helsinn receives European approval of its IV formulation of Akynzeo

23 Mar 2020

The new formulation offers patients in Europe an alternative route of administration of the only fixed antiemetic combination targeting two distinct CINV pathways in a single dose.

Read more 
FDB to triple UK microbial production capacity as Fujifilm commits to $83 million investment

FDB to triple UK microbial production capacity as Fujifilm commits to $83 million investment

19 Mar 2020

Fujifilm Diosynth Biotechnologies will triple microbial production capacity at its UK Teesside facility after joint owner Fujifilm Corporation pledged to invest 9 billion yen (USD83 million) in the biologics focused CDMO.

Read more 
Oxford Biomedica signs LSA with Juno Therapeutics

Oxford Biomedica signs LSA with Juno Therapeutics

19 Mar 2020

Cell and gene focused CDMO Oxford Biomedica (OXB) has signed a licence and clinical supply agreement which could be worth up to USD227 million with Juno Therapeutics, the firms announced Wednesday.

Read more 
CPhI announces new pharma events calendar for 2020

CPhI announces new pharma events calendar for 2020

17 Mar 2020

Organizers secure three new dates for events in Japan, South East Asia and North America in response to COVID-19.

Read more 
Vaxxas HD-MAP to deliver vaccines directly to the skin

Vaxxas HD-MAP to deliver vaccines directly to the skin

17 Mar 2020

Company awarded US$5 million grant for clinical study of measles and rubella vaccination using Vaxxas’ high-density, micro-array patch.

Read more 
Haselmeier receives medical device Master File Number for its injection pen systems

Haselmeier receives medical device Master File Number for its injection pen systems

17 Mar 2020

This documentation will enable customers worldwide to leverage the D-Flex disposable pen system for their combination product development.

Read more 
Medicines for Europe calls for pharma supply chain remedies as COVID-19 pandemic worsens

Medicines for Europe calls for pharma supply chain remedies as COVID-19 pandemic worsens

16 Mar 2020

As the global coronavirus pandemic worsens, generics industry association Medicines for Europe has called for all available European pharmaceutical manufacturing to remain open and running at all times and highlighted the risks to the supply chain that...

Read more 
Technique improves drug delivery system characterization

Technique improves drug delivery system characterization

16 Mar 2020

Postnova Analytics' CF2000 Centrifugal Field Flow Fractionation (CF3) system is delivering exciting new data to scientists developing drug delivery systems.

Read more